Maynard Um
-
-
-
-
-
-
-
Foghorn Therapeutics (FHTX) Reiterated at Buy by Stifel After Q4 Results
-
-
-
-
-
-
-
Guggenheim Starts Foghorn Therapeutics (FHTX) at Buy
-
-
-
-
-
-
-
Citizens JMP Starts Foghorn Therapeutics (FHTX) at Market Outperform
-
-
-
-
-
-
-
Foghorn Therapeutics Inc. (FHTX) to Resume Trading at 7:30 a.m.
-
-
-
-
-
-
-
Foghorn Therapeutics Inc. (FHTX) Tops Q2 EPS by 19c
-
403,154 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

